Evidence discussion
We explain what is established, what remains uncertain and what alternatives exist.
HAIR • REGENERATIVE • EVIDENCE-AWARE
Exosome Hair Therapy
An emerging regenerative concept that requires careful discussion of evidence, product source and regulatory status before any use.
Consultation firstSuitability before treatment
DHA Phase 5Lahore clinic location
Personalised planBuilt around your concern
Clear expectationsNo one-size-fits-all promises
ABOUT THE TREATMENT
Emerging therapy deserves a higher standard of consent.
Exosome products are marketed in regenerative and aesthetic medicine, including for hair loss, but evidence and regulatory status vary by product and country. Lumera Derm does not present exosome therapy as a guaranteed or established cure for hair loss.
01
Assessment First
Your concern, relevant history and treatment goals are reviewed before suitability is discussed.
02
Personalised Planning
The treatment pathway is adapted to your assessment, priorities and realistic goals rather than a fixed protocol.
03
Treatment Delivery
Technique, intensity and treatment details are selected conservatively according to the service and your individual needs.
04
Review & Aftercare
Aftercare and follow-up are used to assess response, support recovery and decide whether further treatment is appropriate.
TREATMENT FOCUS
What matters with Exosome Hair Therapy.
Treatment planning focuses on the factors most relevant to this service, your diagnosis or concern, and safe, realistic outcomes.
Product scrutiny
Source, handling and regulatory status matter for biologic or regenerative products.
Diagnosis first
An emerging therapy should never replace proper evaluation of the cause of hair loss.
Product & regulatory review
Product source, available evidence and local regulatory status are discussed before any regenerative option is considered.
IN MORE DETAIL
Understanding Exosome Hair Therapy.
If an exosome-based option is considered, the conversation should include the diagnosis, alternative treatments with stronger evidence, product provenance, sterility, expected uncertainty and follow-up.
At Lumera Derm, treatment choice follows assessment. The aim is to match the option to the concern, skin or scalp condition, medical history and realistic goals rather than treating a service name as a one-size-fits-all solution.
YOUR VISIT
What to expect at Lumera Derm.
Each service follows the same principle: assess first, explain options clearly, then treat only when appropriate.
01
Consultation
Discuss the concern, goals, relevant history and any previous treatment.
02
Assessment
Confirm suitability, risks, alternatives and whether another pathway would be more appropriate.
03
Treatment Plan
Agree on a conservative, personalised plan with realistic expectations.
04
Review
Follow-up is used to assess response and decide whether any further treatment is worthwhile.
SAFETY & SUITABILITY
What matters before treatment.
Regenerative products marketed as exosomes may be unapproved in some jurisdictions. Availability should depend on local regulation, product verification and clinician judgement.
FREQUENTLY ASKED
Exosome Hair Therapy FAQs.
Clear answers to common questions before you book.
They are an emerging area rather than a universally established standard treatment. Evidence and product quality vary.
No. PRP is prepared from your own blood, while exosome products are manufactured biologic preparations with different regulatory considerations.
No treatment can responsibly guarantee that. Hair-loss response depends on diagnosis, follicle status and many individual factors.
Ask about source, sterility, regulatory status, evidence, storage, administration and known risks.
Depending on diagnosis, established medical therapy, PRP, scalp treatment or other options may be more appropriate.
BOOK A CONSULTATION
Discuss Exosome Hair Therapy with the clinic.
Ask questions, understand suitability and decide on the next step without unnecessary forms.